Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer
Article in Clinical Genitourinary Cancer (January 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma
Article in Cancer Medicine (September 2022)
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies
Article in Cancer Research Communications (July 2022)